Literature DB >> 31084515

The case for a medication first approach to the treatment of opioid use disorder.

Rachel P Winograd1, Ned Presnall2, Erin Stringfellow1, Claire Wood1, Phil Horn1, Alex Duello1, Lauren Green1, Tim Rudder3.   

Abstract

Background: The opioid addiction and overdose crisis continues to ravage communities across the U.S. Maintenance pharmacotherapy using buprenorphine or methadone is the most effective intervention for Opioid Use Disorder (OUD), yet few have immediate and sustained access to these medications.
Objectives: To address lack of medication access for people with OUD, the Missouri Department of Mental Health began implementing a Medication First (Med First) treatment approach in its publicly-funded system of comprehensive substance use disorder treatment programs.
Methods: This Perspective describes the four principles of Med First, which are based on evidence-based guidelines. It draws conceptual comparisons between the Housing First approach to chronic homelessness and the Med First approach to pharmacotherapy for OUD, and compares state certification standards for substance use disorder (SUD) treatment (the traditional approach) to Med First guidelines for OUD treatment. Finally, the Perspective details how Med First principles have been practically implemented.
Results: Med First principles emphasize timely access to maintenance pharmacotherapy without requiring psychosocial services or discontinuation for any reason other than harm to the client. Early results regarding medication utilization and treatment retention are promising. Feedback from providers has been largely favorable, though clinical- and system-level obstacles to effective OUD treatment remain.
Conclusion: Like the Housing First model, Medication First is designed to decrease human suffering and activate the strengths and capacities of people in need. It draws on decades of research and facilitates partnerships between psychosocial and medical treatment providers to offer effective and life-saving care to persons with OUD.

Entities:  

Keywords:  Opioid use disorder; buprenorphine; housing first; low-barrier; medication first; treatment approach

Year:  2019        PMID: 31084515     DOI: 10.1080/00952990.2019.1605372

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  8 in total

1.  Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.

Authors:  Andrea K Finlay; Erica Morse; Matthew Stimmel; Emmeline Taylor; Christine Timko; Alex H S Harris; David Smelson; Mengfei Yu; Jessica Blue-Howells; Ingrid A Binswanger
Journal:  J Gen Intern Med       Date:  2020-06-24       Impact factor: 5.128

2.  Exploring Culturally Based Treatment Options for Opioid Use Disorders Among American Indian and Alaska Native Adults in California.

Authors:  Ingrid Zeledon; Victoria Telles; Daniel Dickerson; Carrie Johnson; Kurt Schweigman; Amy West; Claradina Soto
Journal:  J Stud Alcohol Drugs       Date:  2022-07       Impact factor: 3.346

3.  The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.

Authors:  Caleb J Banta-Green; Mandy D Owens; Jason R Williams; Jeanne M Sears; Anthony S Floyd; Wendy Williams-Gilbert; Susan Kingston
Journal:  Addict Sci Clin Pract       Date:  2022-07-07

4.  A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs.

Authors:  Kathryn Hawk; Lauretta E Grau; David A Fiellin; Marek Chawarski; Patrick G O'Connor; Nikolas Cirillo; Chris Breen; Gail D'Onofrio
Journal:  Acad Emerg Med       Date:  2021-02-28       Impact factor: 3.451

5.  A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.

Authors:  Emmeline N Taylor; Christine Timko; Ingrid A Binswanger; Alex H S Harris; Matthew Stimmel; David Smelson; Andrea K Finlay
Journal:  Subst Abus       Date:  2021-09-29       Impact factor: 3.984

6.  Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic.

Authors:  Jarratt D Pytell; Darius A Rastegar
Journal:  J Subst Abuse Treat       Date:  2020-10-05

7.  Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak.

Authors:  Jesse L Yedinak; Yu Li; Maxwell S Krieger; Katharine Howe; Colleen Daley Ndoye; Hyunjoon Lee; Anna M Civitarese; Theodore Marak; Elana Nelson; Elizabeth A Samuels; Philip A Chan; Thomas Bertrand; Brandon D L Marshall
Journal:  Int J Drug Policy       Date:  2021-07-31

8.  Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration.

Authors:  Kelsey C Priest; Dennis McCarty; Travis I Lovejoy
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.